Otto Benkert

Overview

Best Publications

• Continuity and Discontinuity of Affective Disorders and Schizophrenia: Results of a Controlled Family Study

  W Maier;D Lichtermann;J Minges;J Hallmayer

  530
  Citations

• KOMPENDIUM DER PSYCHIATRISCHEN PHARMAKOTHERAPIE

  Otto Benkert;Hanns Hippius

  363
  Citations

• Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

  Armin Szegedi;Matthias J Müller;Ion Anghelescu;Christoph Klawe

  236
  Citations

• Mirtazapine Compared With Paroxetine in Major Depression

  Otto Benkert;Armin Szegedi;Ralf Kohnen

  191
  Citations

• ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression ☆

  Florian Holsboer;Otto A. Müller;Helmuth G. Doerr;Wolfgang G. Sippell

  190
  Citations

• Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology : A double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist

  H Wetzel;G Gründer;A Hillert;M Philipp

  177
  Citations

• Psychiatric diseases and their treatment in general practice in Germany. Results of a World Health Organization (WHO) study

  Linden M;Maier W;Achberger M;Herr R

  169
  Citations

• A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.

  Otto Benkert;Gerhard Gründer;Hermann Wetzel;David Hackett

  156
  Citations

• Moderate and severe depression: Gradations for the Montgomery–Åsberg Depression Rating Scale

  Matthias J Müller;Armin Szegedi;Hermann Wetzel;Otto Benkert

  152
  Citations

• Neuroendocrine response to antipsychotics : Effects of drug type and gender

  Gerhard Gründer;Hermann Wetzel;Ralf Schlösser;Ion Anghelescu

  146
  Citations

• Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection.

  Otto Benkert;Mechthild Graf-Morgenstern;Andreas Hillert;Jürgen Sandmann

  134
  Citations

• Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report.

  S Schlegel;H Steinert;A Bockisch;K Hahn

  133
  Citations

• Diagnostic value of dexamethasone suppression test in depression.

  F. Holsboer;W. Bender;O. Benkert;H.E. Klein

  126
  Citations

• Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.

  Florian Muller-Siecheneder;Matthias J. Muller;Andreas Hillert;Armin Szegedi

  124
  Citations

• Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.

  A Hillert;W Maier;H Wetzel;O Benkert

  123
  Citations

• Clinical subtypes in panic disorder: their descriptive and prospective validity.

  Raimund Buller;Wolfgang Maier;Otto Benkert

  115
  Citations

• The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).

  Matthias J. Müller;Petra Marx-Dannigkeit;Ralf Schlösser;Hermann Wetzel

  107
  Citations

• Quality of partnership in patients with erectile dysfunction after sildenafil treatment.

  Müller Mj;Ruof J;Graf-Morgenstern M;Porst H

  98
  Citations

• Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.

  Bernd Loerch;Mechthild Graf-Morgenstern;Martin Hautzinger;Sabine Schlegel

  95
  Citations

• A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction.

  M. Philipp;R. Kohnen;O. Benkert

  88
  Citations

• An overview of the clinical efficacy of mirtazapine.

  O. Benkert;M. Muller;A. Szegedi

  21
  Citations